Acenocoumarol-d4 (Synonyms: (±)-Acenocoumarin-d4, (±)-Nicoumalone-d4) |
| Katalog-Nr.GC49614 |
Acenocoumarol-d4 ist deuteriummarkiertes Acenocoumarol.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Acenocoumarol-d4 is intended for use as an internal standard for the quantification of acenocoumarol by GC- or LC-MS. Acenocoumarol is an anticoagulant and vitamin K antagonist.1 It inhibits the reduction of vitamin K1 epoxide to vitamin K1 by vitamin K1 epoxide reductase (VKOR;IC50 = 1.5 and 5.8 nM for VKORC1 and VKORC1L1, respectively).1 Acenocoumarol also inhibits a variety of VKOR mutants in cell-based reporter assays (IC50s = 0.54-11.21 nM).2 It prolongs prothrombin time in rat blood when administered at a dose of 1.5 mg/kg.3
1.Czogalla, K.J., Liphardt, K., HÖning, K., et al.VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sitesBlood Adv.2(6)691-702(2018) 2.Chen, X., Jin, D.-Y., Stafford, D.W., et al.Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieuBlood132(18)1974-1984(2018) 3.Meinertz, T., Kasper, W., Kahl, C., et al.Anticoagulant activity of the enantiomers of acenocoumarolBr. J. Clin. Pharmacol.5(2)187-188(1978)
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *